About Biocatalysis
Biocatalysis is a Healthcare company based in Germany founded in 2002, and was acquired by Cambrex in March 2010. Small molecule drugs and peptides are manufactured by Biocatalysis. Its chief executive, as recorded, is Thomas Loewald. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides.
Company details
Biocatalysis was founded in 2002 in Germany and operates as a contract development and manufacturing organization. Small molecule drugs and peptides are produced through biocatalytic processes for pharmaceutical clients. Services include process development, scale-up, and quality-controlled production. The company is based in Germany, serving the biotech and pharmaceutical sectors with specialized manufacturing capabilities.
- Headquarters Germany
- Stage Acquired
- SectorsHealthcare
- Website biocatalysis.com
- Acquired by Cambrex (Mar 2010)
Investors in Biocatalysis
Biocatalysis has secured backing from 1 investor. Prominent investors backing the company include Cambrex.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CDMO of complex small molecule APIs, including highly potent APIs | 1981 | cambrex.com | East Rutherford, United States |
Investor details for Biocatalysis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biocatalysis
1 people are tracked at Biocatalysis (1 in leadership).
| Name | Role | Group |
|---|---|---|
Thomas Loewald | CEO | Leadership |
Complete people profiles for Biocatalysis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Biocatalysis
2 dated milestones of Biocatalysis across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Biocatalysis is founded.
- Exit Acquired by Cambrex.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biocatalysis
Biocatalysis was founded in 2002.
Biocatalysis is headquartered in Germany.
Thomas Loewald is the CEO of Biocatalysis, as recorded in our data.
Biocatalysis was founded in 2002 in Germany and operates as a contract development and manufacturing organization. Small molecule drugs and peptides are produced through biocatalytic processes for pharmaceutical clients. Services include process development, scale-up, and quality-controlled production. The company is based in Germany, serving the biotech and pharmaceutical sectors with specialized manufacturing capabilities.
Biocatalysis has 1 investor. Key investors include Cambrex.
Yes. Biocatalysis was acquired by Cambrex in March 2010.